Chronic myeloid leukaemia as a model of disease evolution in human cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17522713.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chronic myeloid leukaemia (CML) can be considered as a paradigm for neoplasias that evolve through a multi-step process. CML is also one of the best examples of a disease that can be targeted by molecular therapy; however, the success of new 'designer drugs' is largely restricted to the chronic phase of the disease. If not cured at this stage, CML invariably progresses and transforms into an acute-type leukaemia undergoing a 'blast crisis'. The causes of this transformation are still poorly understood. What mechanisms underlie this progression, and are they shared by other common cancers?
Medical subject headings
- Blast Crisis
- Disease Progression
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Models, Biological